Fernando Rubio is a senior executive with over 25 years of experience leading sales, marketing, operations, and corporate finance across the digital industry. He currently serves as Vice President for the Health vertical at Mercado Libre Latam, driving the regional growth of the healthcare business within the largest e-commerce ecosystem in the region. His career spans e-commerce, fintech, adtech, and digital transformation, including leadership roles at Mercado Ads, Dridco/La Nación, UNO Medios, Bumeran, and Terra/Telefónica, where he managed large teams and scaled multiple business units to double- and triple-digit growth. Fernando has led international expansions, new market launches, complex restructurings, and M&A processes. He completed the Stanford Executive Program, holds an MBA from IAE, and is a CPA from UCA—combining strategic vision, execution speed, and the ability to mobilize teams and transform commercial models at regional scale.

Steven J. Bipes is the Vice President of Global Strategy and Analysis at AdvaMed, where he leads global initiatives in regulatory convergence, market access, and medtech innovation across Latin America, Africa, and other key regions. With deep expertise in international policy and health-system modernization, he works closely with governments and industry partners to expand safe, equitable access to advanced medical technologies worldwide.

Esteban Lifschitz a physician with a strong background in internal medicine, healthcare management, and health economics. He has built a distinguished career at the intersection of clinical practice, health technology assessment, and system-level decision-making, with particular expertise in value-based care, chronic disease management, and evaluation of healthcare innovations.
He currently serves as Scientific Director at HIRIS Care, where he leads the strategic and scientific direction of health intelligence initiatives aimed at improving care quality, clinical outcomes, and sustainability of healthcare systems. His work focuses on translating data and evidence into actionable insights for healthcare organizations and policy leaders across Latin America.
Lifschitz is widely recognized for his ability to bridge clinical knowledge, technology, and health system strategy, contributing to more informed, patient-centered, and value-driven healthcare decisions.

Sebastián García Saisó is a physician and public health specialist with extensive experience in health systems strengthening, evidence-based policy, and population health across the Americas. He is trained in medicine and holds advanced graduate education in health policy, planning, and financing, combining clinical expertise with strong analytical and governance capabilities.
He currently serves as Director of Evidence and Intelligence for Action in Health at the Pan American Health Organization / World Health Organization (PAHO/WHO), where he leads regional efforts on health data, analytics, and the use of evidence to inform public policy and decision-making. His work focuses on improving health outcomes through better use of information, system performance measurement, and strategic health intelligence at scale.

Cristina Simón is a senior finance and infrastructure executive with more than 18 years of experience in social infrastructure development, with a strong focus on healthcare and education systems across Latin America and the Caribbean. Her professional background spans investment structuring, public-private partnerships, and complex infrastructure financing within both private-sector advisory firms and multilateral development institutions.
She holds a degree in Business Administration and Management and a Master’s degree in Corporate Finance and Investment Banking, providing a solid foundation in financial strategy, capital markets, and investment analysis. Throughout her career, she has advised governments and private entities on large-scale infrastructure projects, combining financial discipline with long-term impact objectives.
Cristina currently serves as Head of Social Infrastructure at IDB Invest, where she leads strategy, client engagement, and investment initiatives aimed at expanding access to high-quality, sustainable health and education infrastructure. Her work is characterized by the development of scalable partnership models, strong governance frameworks, and a clear commitment to strengthening social systems through innovative and responsible financing.

Dr. Héctor Castro is a senior health policy and systems expert specialising in health technology assessment (HTA), value-based pricing and market access in emerging markets. With more than 25 years of experience, he was the founding Executive Director of the Institute of Health Technology Assessment (IETS) in Colombia in 2012, served as Director of Innovation & Access to Medicines and Health Technologies at Pan American Health Organization (PAHO), and currently works as Vice President, Health & Life Sciences at Access Partnership, focusing on Latin America and other emerging regions, he is also a director of the board of Health Technology Assessment International (HTAi). Dr Castro holds an MD, an MSc in Health Policy, Planning & Financing from London School of Economics (LSE) / London School of Hygiene & Tropical Medicine (LSHTM), and completed a Takemi post-doctoral fellowship at Harvard T.H. Chan School of Public Health.

Alejandra García is the Deputy Director of Innovation at the National Center for Health Information Systems (CENS) in Chile. She is a member of the Advisory Council of the Women Economic Forum Chile, part of the global G100 network, and recipient of the Innovadoras en Salud Award. A Medical Technologist with an MSc in Biological Sciences and a Diploma in Business Administration, she is also a co-founder of a CEDAI spin-off focused on biomedical and telemedicine imaging. For over a decade, Alejandra has led and managed research and health-technology implementation projects across the public and private sectors.

Dr. Emilio Bueno holds a Doctor of Medicine degree from Pontifícia Universidade Católica de Campinas and a specialization in Health Management from Fundação Getúlio Vargas. He currently serves as Superintendent of Credentialed Network and Supply Chain at Unimed Campinas. Previously, he held several senior leadership roles at UnitedHealth Group and Amil, including Executive Director of Operations for the Americas/Brazil and Chief Medical Officer. His career spans large-scale healthcare operations, clinical governance, and system transformation across major private healthcare networks in Brazil.

Dr. Stephanie Itala Rizk is a physician with strategic expertise at the intersection of healthcare, innovation, and digital transformation, supported by a strong academic and clinical background.
She holds a PhD from the Faculty of Medicine at the University of São Paulo (FMUSP) and is a board-certified Cardiologist and Intensivist. Dr. Rizk practices at the Heart Institute (InCor) of the Hospital das Clínicas, Faculty of Medicine, University of São Paulo, and at Hospital Vila Nova Star, part of the Rede D’Or network.
Recognized for her ability to translate complex clinical and technological challenges into practical, scalable solutions, she combines frontline patient care with active involvement in innovation initiatives aimed at improving quality, efficiency, and access across healthcare systems.
With a systems-oriented mindset, clear communication, and purpose-driven leadership, Dr. Stephanie Itala Rizk is a respected voice in advancing the future of healthcare—where science, technology, and humanity converge.

Dr. Eliézer Silva is a prominent physician-executive with a strong background in Internal Medicine, Intensive Care, and Infectious Diseases, holding a PhD from UNIFESP and postdoctoral training at the University of Colorado. He combines clinical excellence with advanced executive education, including an Executive MBA in Healthcare Management (Insper), the General Management Program at Harvard Business School, and Board training from IBGC.
Currently Executive Director of the Einstein Healthcare System, Dr. Silva plays a key role in leading one of Latin America’s most innovative healthcare ecosystems, integrating care delivery, education, research, and governance. He also serves as a Board Member of RD Saúde, MedSênior, and Gênesis (Fleury Group & Einstein), and is a professor in Einstein’s Executive MBA programs.
At MIND 360, he brings a system-level, C-suite perspective, connecting clinical rigor, strategic leadership, and sustainable healthcare transformation.

Dr. Giselle Coelho is a physician-executive and global leader in digital health and healthcare transformation, currently serving in a senior leadership role at Mayo Clinic, one of the world’s most respected academic medical institutions.
With a strong clinical background and extensive experience in digital transformation, innovation strategy, and large-scale healthcare systems, she has led initiatives across telemedicine, digital platforms, data-driven care models, and patient-centered innovation in complex, high-performance organizations.
Dr. Coelho is recognized for her ability to translate technology and data into measurable clinical impact, combining global vision with pragmatic execution. Her work focuses on building scalable, integrated, and sustainable digital health ecosystems that enhance quality, access, and value in healthcare delivery.
A respected voice in international forums, she actively contributes to shaping the future of connected care, digital ecosystems, and next-generation health systems.

Daniel Greca is a member of the Executive Committee of Hospital Sírio-Libanês, where he leads the Population Health business unit and the Innovation Directorate. Prior to joining Sírio-Libanês, he headed the healthcare vertical at KPMG Brazil, overseeing value-based care initiatives, patient experience programs, and large-scale health system redesign projects. With a background in Biological Sciences and a postgraduate degree in Business, he brings more than 15 years of experience in the health sector. Daniel began his career at Hospital de Clínicas do Paraná in the Bone Bank and Immunopathology unit, later spending eight years in leadership roles supporting research and genomics solutions. Since 2013, he has worked extensively in healthcare and life sciences consulting in both Brazil and the United States.

Dr. Alberto Alves de Lima is a clinical cardiologist and medical education leader with extensive experience in healthcare, academia, and research. He holds a PhD and a Master’s in Health Professions Education from Maastricht University, alongside his medical and cardiology training in Argentina. Dr. Lima has held key leadership roles, including Medical Director of the Instituto Cardiovascular de Buenos Aires (ICBA), President and Medical Director of the Fundación Cardiovascular de Buenos Aires, and Director of Research and Education at ICBA. He has also served as Director of the Cardiology Specialist Program at the University of Buenos Aires and as a researcher at CONICET. Recognized for his contributions to cardiology, scientific advancement, and the training of health professionals, he has built a career dedicated to strengthening clinical excellence and institutional development.

Dr. Carlos Kerguelen is a physician and healthcare management specialist with advanced training in patient safety, quality, and clinical performance from leading institutions such as Johns Hopkins, the University of Michigan, and IHI Boston. He holds a Master’s in Health Management, Planning, and Policy from the University of Leeds and is recognized as an ISQua Expert.
He currently serves as Deputy Director of Clinical Performance Metrics at Fundación Santa Fe de Bogotá, leading initiatives to enhance quality, safety, and hospital performance. His experience includes supporting hospitals, government agencies, academic institutions, and multinational organizations in strengthening health systems, implementing DRGs, and improving patient safety. He is also a postgraduate lecturer and a frequent national and international speaker in quality and patient safety.

Dr. Andrés Aguirre Martínez is one of Colombia’s most respected healthcare leaders, recognized for more than two decades of transformative leadership at Hospital Pablo Tobón Uribe in Medellín, where he served as Director for over 22 years. Under his guidance, the institution evolved into a national reference in clinical excellence, human-centered care, and high-quality hospital management, achieving major milestones in accreditation, reputation, and infrastructure expansion.
His leadership style is widely admired for its focus on compassion, values-driven decision-making, team empowerment, and the belief that great hospitals are built through purpose and culture as much as through technology or infrastructure. He has been recognized nationally for his contributions, including the distinction of “Colombiano Ejemplar” in the health category.

Dr. Pedro Silva Correa de Magalhães. Graduated in Medicine from UCPEL - Universidade Católica de Pelotas, Pelotas - RS (2005). Neurology Residency at Hospital Municipal São José (HMSJ), Joinville - SC (2006-2008). Fellowship in Diagnostic and Interventional Neuroradiology at HMSCPA - Complexo Hospitalar Santa Casa de Misericórdia, Porto Alegre - RS (2009-2010). Research Fellowship in Interventional Neuroradiology at Ronald Reagan Hospital - UCLA, Los Angeles - USA (2011).MBA in Health Management and Innovation. Green Belt Specialist in Value-Based Health Care (VBHC). Coordinator of VBHC Implementation and Initiatives at Joinvasc, including Cost and Cost-Effectiveness Research.

Dr. Ricardo de Carvalho Cavalli is Full Professor at the Ribeirão Preto Medical School (USP) and CEO (Superintendent) of the Hospital das Clínicas of Ribeirão Preto, one of Latin America’s leading academic hospitals. With postdoctoral training at Harvard Medical School, he brings a system-level perspective on public healthcare, hospital governance, innovation, and sustainable integration of new technologies.

Dr. Partha Kar is a Consultant Diabetologist at Portsmouth Hospital-Health NHS Trust and National Specialty Advisor for Diabetes at NHS England. A recognized global voice in diabetes care, he is known for driving system transformation, patient-centered innovation, and equity in access, bridging clinical practice, policy, and real-world impact.

Dr. Anwar Medellín is a renowned coloproctologist and colon and rectal surgeon in Colombia, specialized in the treatment of benign and malignant diseases of the colon, rectum and anus, with extensive experience in minimally invasive surgery (laparoscopic and robotic) and personalized cancer treatments, leading the colorectal surgery section at the Santa Fe Foundation in Bogotá.

Dr. Carlos Perona - Cardiologist and Electrophysiologist. Currently Team Leader of the Department of Electrophysiology and Cardiac Stimulation at the Santojanni Hospital in Buenos Aires - Argentina. Known for his extensive experience in different private institutions in Argentina, including Sanatorio Trinidad Quilmes, and leader of academic reference in electrophysiology in Latin America.

Dr. Eduardo Agustín Arias Sánchez. Interventional Cardiologist. Currently Head of Service of the Department of Hemodynamics and Interventional Cardiology of the Ignacio Chavez National Institute of Cardiology in Mexico. Known for his academic contribution as an associate professor at the Institute of Cardiology of the UNAM.

Dr. Carlos Tapias.  Cardiologist and Electrophysiologist.  Currently Electrophysiologist of the Electrophysiology Service of the Cardioinfantil Foundation in Colombia. Known for his contributions as coordinator of the Cardiovascular Electrophysiology Program of the Universidad De La Sabana – Fundación Cardioinfantil in Colombia.

DMO Company is a leading provider of integrated digital and clinical-innovation solutions, supporting health systems in modernizing care from diagnosis to advanced procedures. The company works with major private hospital networks, public and academic medical centers, integrated delivery systems, specialty clinics, government stakeholders, and medtech industry partners. Together with these clients, DMO delivers scalable technologies and operational models that enhance efficiency, elevate quality, and create real value across the entire patient journey.